Receptors, Mineralocorticoid
"Receptors, Mineralocorticoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cytoplasmic proteins that specifically bind MINERALOCORTICOIDS and mediate their cellular effects. The receptor with its bound ligand acts in the nucleus to induce transcription of specific segments of DNA.
Descriptor ID |
D018161
|
MeSH Number(s) |
D12.776.826.750.530
|
Concept/Terms |
Receptors, Mineralocorticoid- Receptors, Mineralocorticoid
- Mineralocorticoid Receptors
- Receptors, Mineralocorticoids
- Mineralocorticoids Receptors
- Mineralocorticoid Receptor
- Receptor, Mineralocorticoid
Receptors, Corticoid Type I- Receptors, Corticoid Type I
- Corticoid Type I Receptors
- Receptors, Corticoid I
- Corticoid I Receptors
- Corticoid I Receptor
- Receptor, Corticoid I
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Mineralocorticoid".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Mineralocorticoid".
This graph shows the total number of publications written about "Receptors, Mineralocorticoid" by people in this website by year, and whether "Receptors, Mineralocorticoid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Mineralocorticoid" by people in Profiles.
-
Glucocorticoids with or without fludrocortisone in septic shock: a narrative review from a biochemical and molecular perspective. Br J Anaesth. 2024 Jan; 132(1):53-65.
-
Impact of aldosterone receptor blockade on the deleterious cardiac effects of adrenergic activation in hypertensive rats. J Cardiovasc Pharmacol. 2010 Aug; 56(2):203-11.
-
Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation. Hypertension. 2005 May; 45(5):914-20.